ATA112473A - Verfahren zur herstellung von neuen 15alpha,16alpha-methylen-4-ostren-17beta-olen - Google Patents

Verfahren zur herstellung von neuen 15alpha,16alpha-methylen-4-ostren-17beta-olen

Info

Publication number
ATA112473A
ATA112473A AT112473A AT112473A ATA112473A AT A112473 A ATA112473 A AT A112473A AT 112473 A AT112473 A AT 112473A AT 112473 A AT112473 A AT 112473A AT A112473 A ATA112473 A AT A112473A
Authority
AT
Austria
Prior art keywords
ostrene
15alpha
16alpha
olen
17beta
Prior art date
Application number
AT112473A
Other languages
English (en)
Other versions
AT327413B (de
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Priority to AT1039174A priority Critical patent/AT339514B/de
Publication of ATA112473A publication Critical patent/ATA112473A/de
Application granted granted Critical
Publication of AT327413B publication Critical patent/AT327413B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT112473A 1972-02-11 1973-02-08 Verfahren zur herstellung von neuen 15alpha,16alpha-methylen-4-ostren-17beta-olen AT327413B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT1039174A AT339514B (de) 1972-02-11 1974-12-30 Verfahren zur herstellung von neuen 15alfa,16alfa-methylen-4-ostren-17beta-olen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2207421A DE2207421C3 (de) 1972-02-11 1972-02-11 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
ATA112473A true ATA112473A (de) 1975-04-15
AT327413B AT327413B (de) 1976-01-26

Family

ID=5836211

Family Applications (1)

Application Number Title Priority Date Filing Date
AT112473A AT327413B (de) 1972-02-11 1973-02-08 Verfahren zur herstellung von neuen 15alpha,16alpha-methylen-4-ostren-17beta-olen

Country Status (29)

Country Link
JP (1) JPS5829317B2 (de)
KR (1) KR780000156B1 (de)
AT (1) AT327413B (de)
AU (1) AU467306B2 (de)
BE (1) BE795241A (de)
CA (1) CA997753A (de)
CH (2) CH593995A5 (de)
CS (1) CS193019B2 (de)
DD (1) DD102379A5 (de)
DE (1) DE2207421C3 (de)
DK (1) DK131037B (de)
EG (1) EG10914A (de)
ES (1) ES410933A1 (de)
FI (1) FI52225C (de)
FR (1) FR2181719B1 (de)
GB (1) GB1425636A (de)
GR (1) GR63160B (de)
HU (1) HU165253B (de)
IE (1) IE37266B1 (de)
IL (1) IL41506A (de)
NL (1) NL177217C (de)
NO (2) NO140304C (de)
PH (1) PH9370A (de)
PL (1) PL81084B1 (de)
RO (1) RO73527A (de)
SE (3) SE403781B (de)
SU (1) SU513628A3 (de)
YU (1) YU35035B (de)
ZA (1) ZA73944B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007027637A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027636A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT274653B (de) * 1966-11-10 1969-09-25 Alexander Schoeller & Co Kg Stapelbarer, quaderförmiger, geschlossener Transportbehälter aus Kunststoff für feinkörnige Schüttgüter und Flüssigkeiten

Also Published As

Publication number Publication date
NL177217C (nl) 1985-08-16
IE37266B1 (en) 1977-06-08
AU467306B2 (en) 1975-11-27
FR2181719A1 (de) 1973-12-07
EG10914A (en) 1976-09-30
NO140304C (no) 1979-08-08
SE403781B (sv) 1978-09-04
CH593995A5 (de) 1977-12-30
DE2207421A1 (de) 1973-08-16
RO73527A (ro) 1982-02-01
IL41506A (en) 1976-07-30
FI52225B (de) 1977-03-31
DD102379A5 (de) 1973-12-12
CA997753A (en) 1976-09-28
AU5207673A (en) 1974-08-15
GB1425636A (en) 1976-02-18
FI52225C (fi) 1977-07-11
GR63160B (en) 1979-09-25
DE2207421B2 (de) 1980-07-24
ZA73944B (en) 1973-11-28
HU165253B (de) 1974-07-27
ES410933A1 (es) 1976-03-01
SE7713896L (sv) 1977-12-07
YU24373A (en) 1979-12-31
CH590883A5 (de) 1977-08-31
BE795241A (fr) 1973-08-09
PH9370A (en) 1975-10-22
SE7514513L (sv) 1975-12-22
NL7301974A (de) 1973-08-14
NO140304B (no) 1979-04-30
AT327413B (de) 1976-01-26
DK131037B (da) 1975-05-20
KR780000156B1 (en) 1978-05-02
NO143065C (no) 1980-12-10
SE426834B (sv) 1983-02-14
SE409329B (sv) 1979-08-13
FR2181719B1 (de) 1975-11-21
JPS5829317B2 (ja) 1983-06-22
NO782754L (no) 1973-08-14
DE2207421C3 (de) 1981-05-07
IL41506A0 (en) 1973-04-30
IE37266L (en) 1973-08-11
NL177217B (nl) 1985-03-18
PL81084B1 (de) 1975-08-30
SU513628A3 (ru) 1976-05-05
JPS4886856A (de) 1973-11-15
CS193019B2 (en) 1979-09-17
NO143065B (no) 1980-09-01
YU35035B (en) 1980-06-30
DK131037C (de) 1975-10-20

Similar Documents

Publication Publication Date Title
AT327181B (de) Verfahren zur herstellung von neuen phenylindanestern
AT329203B (de) Verfahren zur herstellung von neuen heptapeptiden
ATA583473A (de) Verfahren zur herstellung von neuen sufonamidodiphenylathern
ATA993573A (de) Verfahren zur herstellung von neuen cephalosporinathern
AT329045B (de) Verfahren zur herstellung von neuen, basisch substituierten indanderivaten
AT325605B (de) Verfahren zur herstellung von neuen alpha-phenylindolderivaten
ATA770674A (de) Verfahren zur herstellung von neuen penicillinen
AT330955B (de) Verfahren zur herstellung von neuen beta-lactamen
AT325767B (de) Verfahren zur herstellung von neuen penicillinen
AT329177B (de) Verfahren zur herstellung von neuen penicillinen
AT325203B (de) Verfahren zur herstellung von neuen penicillinen
AT326268B (de) Verfahren zur herstellung von neuen penicillinen
AT328096B (de) Verfahren zur herstellung von neuen n(heteroarylmethyl)-7alpha-acyl-6,14-endoatheno-tetrahydro-nororipavinen und -thebainen
AT323189B (de) Verfahren zur herstellung von neuen lactamen
AT331805B (de) Verfahren zur herstellung von neuen triazinobenzimidazolen
AT324561B (de) Verfahren zur herstellung von neuen penicillinen
AT327413B (de) Verfahren zur herstellung von neuen 15alpha,16alpha-methylen-4-ostren-17beta-olen
AT340069B (de) Verfahren zur herstellung von neuen prostaglandinen
AT326841B (de) Verfahren zur herstellung von neuen 15alfa,16alfa-methylen-4-pregnenen
AT334879B (de) Verfahren zur herstellung von neuen arylathern
AT333740B (de) Verfahren zur herstellung von neuen indanderivaten
AT338229B (de) Verfahren zur herstellung von neuen aldehydolactonen
AT331971B (de) Verfahren zur herstellung von neuen 3-monoestern von rosamicin
AT330356B (de) Verfahren zur herstellung von neuen penicillinen
ATA967374A (de) Verfahren zur herstellung von neuen oxaprostaglandinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
UEP Publication of translation of european patent specification